Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Piccolo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Hepatology|April 27, 2019
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life studyRaffaella Lionetti, Paola Piccolo, Ilaria Lenci, et al.
Clinical Transplantation|December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective studyRaffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2021
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipientsGianpiero D'Offizi, Chiara Agrati, Ubaldo Visco-Comandini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 17, 2023
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipientsMarzia Montalbano, Paola Piccolo, Raffaella Lionetti, et al.
European Journal of Public Health|November 4, 2009
Patterns of chronic hepatitis B in Central Italy: a cross-sectional studyPaola Piccolo, Ilaria Lenci, Claudia Telesca, et al.
European Journal of Gastroenterology & Hepatology|August 6, 2008
Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis CMario Angelico, Beate Koehler-Horst, Paola Piccolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2013
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: the TT4 randomized trialSimona Francioso, Cristiana Almerighi, Paolo Forte, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Hepatology|April 27, 2019
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life studyRaffaella Lionetti, Paola Piccolo, Ilaria Lenci, et al.
Clinical Transplantation|December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective studyRaffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2021
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipientsGianpiero D'Offizi, Chiara Agrati, Ubaldo Visco-Comandini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 17, 2023
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipientsMarzia Montalbano, Paola Piccolo, Raffaella Lionetti, et al.
European Journal of Public Health|November 4, 2009
Patterns of chronic hepatitis B in Central Italy: a cross-sectional studyPaola Piccolo, Ilaria Lenci, Claudia Telesca, et al.
European Journal of Gastroenterology & Hepatology|August 6, 2008
Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis CMario Angelico, Beate Koehler-Horst, Paola Piccolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2013
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: the TT4 randomized trialSimona Francioso, Cristiana Almerighi, Paolo Forte, et al.
Pageof 2